The Importance of Microstructure in Topical Drug Product Development
The interview will examine the importance of Microstructure in topical pharmaceutical drug development and how BASF is playing an integral leading role in this ‘hot topic’ in the Industry. Information will be provided that highlights the importance of this topic as it relates to the FDA and complex regulatory landscape. BASF will also describe its current work in this area as well as future steps.
The interview will examine the importance of Microstructure in topical pharmaceutical drug development and how BASF is playing an integral leading role in this ‘hot topic’ in the Industry. Information will be provided that highlights the importance of this topic as it relates to the FDA and complex regulatory landscape. BASF will also describe its current work in this area as well as future steps.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
PacBio Chosen as Tech Partner for Global Alzheimer’s Disease Research Project
April 23rd 2025The project, the North African Dementia Registry, will unite multiple entities for the purpose of developing a comprehensive dataset to advance the research community’s understanding of Alzheimer’s disease and other dementias in diverse populations.
